Research Grade Veltuzumab (DHC90711)

Published date: 2023-11-24 09:56:18

Research Grade Veltuzumab (DHC90711) Structure
Share to Facebook Share to Twitter Share to Linkedin
Name VeltuzuMab CAS# 728917-18-8
Price ¥Inquiry/1kg ¥Inquiry/1g ¥Inquiry/1mg ¥Inquiry/1ton Purity 1.0%
Stocking
Period
Inquiry Stock Inquiry
Product Webpage: https://www.antibodysystem.com/product/131.html
 Detail Product Information
Catalog No.
DHC90711

Host species
Humanized

Species reactivity
Human

Form
Liquid

Storage buffer
0.01M PBS, pH 7.4.

Concentration
1 mg/ml

Purity
>95% by SDS-PAGE.

Clonality
Monoclonal

Isotype
IgG1-kappa

Applications
Research Grade Biosimilar

Target
B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20

Purification
Protein A or G purified from cell culture supernatant.

Endotoxin level
Please contact with the lab for this information.

Expression system
XtenCHO

Accession
P11836

Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Alternative Names
hA20 / IMMU-106, CAS: 728917-18-8

Note
For research use only. Not suitable for clinical or therapeutic use.
More

Supplier/Manufacture

Biolab Reagents

Chemsrc Level: Unverified
Tel: 027-65279366
Address: Building C, No. 666, Shen Dun Si Lu Wuhan, CHINA
Area: China
Contact: fang
Contact Phone #: 18108604356
Email: info@biolabreagent.com
Website: https://www.biolabreagent.com/
Annual Trade Volume:
Foreign Trade % of Sales:
Major partners: AntibodySystem
Wuhan Biolab Reagents was founded in 2021. Its core founding team comprises five top-tier researchers in the life sciences, graduates of Wuhan University, Huazhong University of Science and Technology, Huazhong Agricultural University, and other leading institutions. With over two decades of collective industry experience, the team has built solid capabilities in product development and applied technology, laying a robust technological foundation for the company.

Recognized as a National High-tech Enterprise and a National Technology-based SME, the company’s technical expertise has received authoritative endorsement. It also holds dual certification under ISO9001 and ISO13485 quality management systems, ensuring standardized quality control and reliable product performance. Leveraging globally advanced technology platforms, Biolab Reagents focuses on the global development and integration of high-quality biological reagents. It serves as the exclusive authorized partner in Asia for France’s AntibodySystem and as an agent for Sangon Biotech’s KleanAB brand. The company currently boasts a product portfolio of approximately 60,000 reagents, with core offerings spanning proteins, antibodies, and assay kits. These products primarily support research in areas such as oncology and neurological diseases, catering to diverse scientific needs.

Since its inception, Biolab Reagents has been committed to providing researchers and industrial clients in biomedicine with professional products and technical support. By offering premium research tools, the company empowers scientific exploration and contributes to innovation and breakthroughs in life sciences research.